Hetalox specialization and why it matters
At Hetalox, we specialize in the early detection and in-depth analysis of brain atrophy using advanced AI-driven MRI analysis.
Tag: healthcareinnovation
-
-
We begin acceleration in the Startup Booster for Social Impact program
In cooperation with 24ventures fund and mentors we are going to conduct pilot studies that will verify the effectiveness of the platform in clinical conditions and more.
-
Hetalox at the 6th Saxon-Polish Innovation Day
We were honored to participate in the 6th Saxon-Polish Days, where Hetalox was proudly represented by our team
-
Made in Wrocław 2024
Hetalox participated in VC Demo Day during the Made in Wrocław 2024 event, showcasing our AI-driven solutions for medical imaging.
-
Our workshop at MICCAI 2024
We had an incredible time at the MICCAI 2024 Conference during the CLINICCAI (Clinical Translation of Medical Image Computing and Computer-Assisted Interventions), where we had the pleasure to present the work with significant contributions from Hetalox.
-
The evolving landscape of Alzheimer’s treatment: Understanding Amyloid-Related Imaging Abnormalities (ARIAs)
In this post, we delve into the evolving landscape of Alzheimer’s treatment, focusing on the role of Amyloid-Related Imaging Abnormalities (ARIAs) in patients undergoing β-amyloid–targeting therapies.